Natco Pharma | Sudip Bandhopadhyay’s Value Pick

By | 12th April 2018

For a long period, Natco Pharma will give you a fantastic return

Market expert Sudip Bandopadhyay has opted for Natco Pharma as a Value Pick. Sudeep Bandopadhyay said that Natco Pharma has a focus on R & D. The company has a wide business in many segments. Natco Pharma‘s valuation looks better than the rest of the sector. Natco Pharma‘s EBITDA data margin has remained steady. Natco Pharma will focus on the launch of new drugs.

Sudeep Bandopadhyay advises that investing in Natco Pharma at current levels can earn good returns. Sudeep Bandopadhyay believes that in the 12-month period, Natco Pharma can see the level of 900 rupees. Presently the stock price of Natco Pharma is around 780 rupees.

CMP Rs.: 780

Target Rs.: 900

Upside: 15.83%

Time Frame: 12 months



See also: Havells India Ltd – Fundamental Analysis

Our Blog website:

Follow us on Facebook:

Follow us on YouTube:


My descriptions, videos, presentations are only for educational and information purposes and under no circumstances should be used for making investment decisions. I cannot guarantee the accuracy of any information provided.
The stocks picks are based on my own research and personal views and sometimes are from newspapers, tv channel program, magazines, etc. In addition, No part of compensation is or will be directly or indirectly related to the views and recommendations of this research. I have not served as an officer director or employee of the company and have not been engaged in the market – making the activity of the company covered in the research report. Hence Consult qualified financial advisor before making any investment decision.

Leave a Reply

Your email address will not be published. Required fields are marked *